Nasseo Wins CONNECT Life Sciences Capital Competition and Joins CONNECT Portfolio

Share Article

Nasseo, Inc. is honored to announce that it has won the CONNECT Life Sciences Capital Competition and has subsequently earned the distinction of becoming a CONNECT Portfolio Company. As a result, Nasseo will be presenting at the March 14th Capital Roadshow in Palo Alto, CA and at the April 12th Rock Stars of Innovation Summit in San Diego, CA.

Nasseo, Inc. - The Future of Dental Implants

“CONNECT has offered us a number of dynamic opportunities to grow our company. We look forward to the opportunity to introduce the Nasseo TiArray™ dental implant system to a new audience of VCs at the March 14th Capital Roadshow."
-Dr. Smith, CEO

Nasseo, Inc. is honored to announce that it has won CONNECT’s Life Sciences Capital Competition and has subsequently earned the distinction of becoming a CONNECT Portfolio Company. Competing against a large pool of highly qualified California-based life science companies, Nasseo was selected by a panel of distinguished judges for its “radical innovation in the Southern California start-up scene”. Pursuant to its victory, the Company has been invited to present its proprietary implant surface modification technology for dental and orthopedic applications to a group of venture capital investors at the March 14th Capital Roadshow in Palo Alto, California at the offices of Morrison & Foerster.

Nasseo’s first product, the TiArray™ Dental Implant is an easy-to-use, cost-effective dental implant system for patients with poor circulatory issues (e.g. diabetics, smokers) as well as for the general population. Nasseo’s technology addresses the ongoing problem of dental implant failures, which account for $1.2B annually in patient healthcare costs in the United States.

Nasseo’s selection earlier this year to CONNECT Springboard, a distinguished business mentorship and networking program, was a key milestone for the company. The CONNECT Springboard program introduced Nasseo to serial life sciences entrepreneur Bill Gerhart for executive mentorship. Mr. Gerhart was previously Founder, President & CEO of Elevation Pharmaceuticals, which developed new aerosol therapies for underserved respiratory patient populations, and which he sold in 2012 to Sunovion Pharmaceuticals for up to $430 million. After undergoing a rigorous screening and completing the mentoring process with Gerhart, Nasseo was further vetted to present in the CONNECT Life Sciences Capital Competition.

Dr. Garrett Cale Smith, PhD, CEO of Nasseo says, “Bill Gerhart has successfully led several life sciences companies through the growth stages that Nasseo is now experiencing. His insight on how to strategically position the company for investment was instrumental. We are grateful for his continued support.”

Nasseo’s TiArray™ dental implant product and its proprietary technology have drawn significant interest from the scientific and investment communities. Last year, the company presented at World’s Best Technology (WBT) Innovation Marketplace 2012, and also received the 1st place prize at the 6th Annual UC San Diego Entrepreneur Challenge Business Plan Competition, where it was the first startup to ever win both the UCSD Entrepreneur Challenge Executive Summary and Business Plan Competitions in the same year. Nasseo most recently announced that it had been selected into the BioInspire™ medical technology incubator, and had subsequently closed its $520K seed round of funding.

Dr. Garrett Cale Smith, PhD, CEO of Nasseo, says, “CONNECT has offered us a number of dynamic opportunities to grow our company. We look forward to the opportunity to introduce the Nasseo TiArray™ dental implant system to a new audience of VCs at the March 14th Capital Roadshow.”

Additionally, CONNECT has invited Nasseo to be one of eight emerging companies across all disciplines to present at its annual Rock Stars of Innovation Summit in San Diego on April 12, a premier showcase at the Hard Rock Hotel to be attended by over 250 technology and investment leaders. The company is moving forward with plans to raise a $3M+ Series A investment round in mid 2013 to catalyze production and sales.

About Nasseo, Inc.
Nasseo, Inc. is a medical device company using state of the art surface modification technology to provide patients and clinicians with the next generation of dental and orthopedic implants. The company is based in San Diego, CA. For more information, please visit us at http://www.nasseo.com or contact us at info@nasseo.com.

Share article on social media or email:

View article via:

Pdf Print

Contact Author

Kayvon Pourmirzaie
Follow us on
Visit website